Author: admin

04 May Why do a Study Like That?

By Ramesh Nathan, MD I recently was invited to participate in a research study, looking at the economic impact of a new drug for the treatment of Clostridium difficile infection.  The new drug, called Fidaxomicin, has been available for a few years and has proven efficacy...

Read More

13 Apr I am not an Economist

By Marty Muntz, MD, FACP I am not an economist. This is how I start my high-value care session during the internal medicine clerkship orientation day at MCW, and it is absolutely true.  It doesn’t take an economist, though, to realize that healthcare is too expensive.  Healthcare spending...

Read More

02 Mar What Could Be the Harm?

Eric Mandelbaum RN, MBA Managing diabetes is all about control: controlling what you eat, when you eat, and the amount of insulin you give yourself. As someone with type 1 diabetes, I understand how control over one’s blood glucose levels is vital to maintaining a healthy...

Read More